TickerFacts.

Travere Therapeutics, Inc. (TVTX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$280.69M
Year ended 2023-12-31
$6.52M2012-12-31: -$2.76M2013-12-31: -$17.71M2015-12-31: -$1.41M2016-12-31: -$4.87M2017-12-31: $6.52M2018-12-31: -$25.68M2019-12-31: -$58.41M2020-12-31: -$49.51M2021-12-31: -$19.89M2022-12-31: -$186.48M2023-12-31: -$280.69M-$280.69M
2012-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$280.69Mn/m2026-02-19, From 2023-01-01
2022-12-31-$186.48Mn/m2025-02-21, From 2022-01-01
2021-12-31-$19.89Mn/m2024-02-20, From 2021-01-01
2020-12-31-$49.51Mn/m2023-02-23, From 2020-01-01
2019-12-31-$58.41Mn/m2022-02-24, From 2019-01-01
2018-12-31-$25.68Mn/m2021-03-01, From 2018-01-01
2017-12-31$6.52Mn/m2020-02-24, From 2017-01-01
2016-12-31-$4.87Mn/m2019-02-26, From 2016-01-01
2015-12-31-$1.41Mn/a2018-07-06, From 2015-01-01
No annual figure between 2013-12-31 and 2015-12-31.
2013-12-31-$17.71Mn/m2016-02-26, From 2013-01-01
2012-12-31-$2.76Mn/a2015-07-09, From 2012-01-01